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We report a case of severe intrauterine hemolysis caused by sole anti-E alloimmunization. A 36-year-old multipara woman
presented with hydrops fetalis at 27 weeks of gestation. She had a history of previous neonatal death. In this pregnancy, she was
foundtohaveveryhightiterofanti-Eantibody.Ultrasonographydetectedmarkedskinedema,cardiomegaly,hepatosplenomegaly,
pleural eﬀusion, ascites, placentomegaly, and polyhydramnios. The Doppler peak systolic velocity in the middle cerebral artery
was 0.8m/s, indicating severe fetal anemia. Multiple intrauterine transfusions for the anemic fetus were administered. However,
persistent severe fetal anemia and placentomegaly caused poor neonatal death and mirror syndrome in the mother. Uncommon
redbloodcell alloimmunization hastobewatched forearly inanypopulation, especially inawoman witha historyofunexplained
perinatal loss.
Copyright © 2009 An-Shine Chao et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Antibodies with anti-E speciﬁcity are detected in 14–20% of
pregnant women and it is one of the most common non-
D Rhesus (Rh) antibody in the pathogenesis of neonatal
hemolytic disease [1, 2]. However, anti-E is rarely associated
with severe hemolytic anemia in the fetus [3, 4]. We report
an unusual case of severe intrauterine hemolysis due to anti-
E alloimmunization.
2. Case Presentation
A 36-year-old woman, G5P2AA1, was referred to our clinic
at 27 weeks gestation due to the presence of hydrops
fetalis. Antenatal examination at outside hospital is non-
contributory for any hydrops fetalis. She had two previous
cesarean sections without history of blood transfusion.
The ﬁrst baby was a term live-born. The second baby
was born at 36 weeks gestation died in a few days after
birth of unknown neonatal hepatomegaly only 3 years
ago. Sonography of the fetus revealed marked skin edema,
cardiomegaly, hepatosplenomegaly, pleural eﬀusion, ascites,
placentomegaly, and polyhydramnios. Doppler peak systolic
velocity (PSV) in the middle cerebral artery (MCA) was
0.8m/s (>2.0 multiples of median) (MoM), indicating severe
fetal anemia (Figure 1). Studies on karyotype, thalassemia,
Parvovirus B19, cytomegalovirus, Toxoplasmosis, and antin-
uclear antibodies were all normal. Both parents had O and
D+ blood type. Indirect Coombs’ test was positive and high
titer of anti-E antibodies with antihuman globulin titers of
1 : 1024 was noted in the maternal blood. Rh typing of
the mother was D(+) E(−)c ( −) C(+) e(+). Severe fetal
anemia was conﬁrmed by umbilical cord blood sampling
with hemoglobin (Hb) level of 2.1g/dL and hematocrit
of 6.1%. The phenotype of fetal red blood cells (RBCs)
was O, D (+) E(+) c(+) C(+) e(+) and strong positive in
direct Coombs’ test (++++). Three times of 20mL each in
every week antenatal transfusions of irradiated Group O, D+
packed RBCs were administered between 28 and 30 weeks of
gestation. Fetal anemia persisted between Hb levels between
3-4g/dL with no improvement of hydrops and Doppler ﬂow
studies. She developed preeclampsia with elevated blood2 Case Reports in Medicine
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Figure 1: Doppler peak systolic velocity in the fetal middle cerebral
artery showing severe fetal anemia.
pressureandgeneraledema.Cesareansectionwasperformed
at 31 weeks gestation after steroid administration for the
mother who had twice section, delivering a 2000g male baby
with Apgar scores of 2 and 3 at 1 and 5 minutes, respectively.
The placenta was bulky and grossly edematous weighing
1300g. Even with multiple blood transfusions, the newborn
succumbed in 2 days. Autopsy was declined.
3. Discussion
Anti-E alloimmunization can cause fetal anemia, and the
incidence could be underestimated [5]. Only a few reports
of pregnancy loss due to anti-E were described [4, 6]. Unlike
anti-D alloimmunization, anti-E titer is less sensitive in
detecting severity of hemolysis in the subsequent pregnancy.
Therefore, high level of suspicion and early recognition of
these cases is crucial even with low titers. A critical titer of
1 : 16 has been considered in anti-E alloimmunization [4].
Joy et al. reported that six of the 16 fetuses with maternal
titer greater than 1 : 16 had fetal Hb less than 10g/dL. Two
fetal hydrops resulted in perinatal death despite intrauterine
treatment. Extremely elevated titer coupled with very severe
fetal anemia as in this present study is scarce [4, 6].
Using a cut-oﬀ of 1.5MoM in the MCA of PSV Doppler
studies, 100% sensitivity in the prediction of moderate
to severe fetal anemia was reported [7]. If MCA PSV is
added, fetal anemia is treatable with favorable outcome of
over 90% before hydrops [8]. Fetal hydrops combined with
very low cord blood Hb (2.1g/dL) is a late and ominous
presentation of hemolytic disease. Encountering this adverse
clinical setting, receiving blood transfusions in our case was
in vain.
An uncommon consequence of fetal hydrops that will
worsen the condition is the development of maternal mirror
syndrome. The trigger of rapid body weight gain, hydram-
nios, elevated blood pressure, and general edema in mirror
syndrome may be derived from a compromised fetus or
placenta. Immediate delivery should be performed to avoid
maternal morbidity.
In conclusion, we advocate that in D+ women who had
previous unexplained fetal loss (fetal hydrops), screening of
maternal serum alloantibodies against RBCs is important
in the early trimesters of pregnancy, followed by regular
Dopplerstudiesandtreatmentstrategiesifalloimmunecause
of hemolysis is identiﬁed.
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